SCHEMBL3101255

SCHEMBL3101255

O=C(NCCC1CCCCC1)c1cc2ccccc2nc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.60
RAB9A P51151 2/20 0.60
KDM4E B2RXH2 1/20 0.60
ALDH1A1 P00352 1/20 0.60
HTT P42858 2/20 0.55
NPC1 O15118 2/20 0.49
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
BACE1 P56817 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
CHRM1 P11229 1/20 0.43
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
IL1B P01584 1/20 0.43
CHRM4 P08173 1/20 0.43
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3094460 0.88 SMN1; SMN2 (0.69) SMN1; SMN2RAB9AKDM4EALDH1A1HTT
SCHEMBL3111861 0.78 SMN1; SMN2 (0.68) SMN1; SMN2RAB9AKDM4EALDH1A1HTT
SCHEMBL3455872 0.77 RAB9A (0.55) SMN1; SMN2RAB9ANPC1L3MBTL1CHRM1
SCHEMBL1721491 0.75 NPC1 (0.39) SMN1; SMN2RAB9AALDH1A1NPC1L3MBTL1
SCHEMBL34468763 0.73 SMYD3 (0.58) RAB9AKDM4EALDH1A1NPC1L3MBTL1
SCHEMBL5139948 0.72 HTT (0.60) SMN1; SMN2RAB9AKDM4EALDH1A1HTT
SCHEMBL26098577 0.72 CDK1 (0.59) RAB9AALDH1A1NPC1L3MBTL1GAA
SCHEMBL8396478 0.71 SMN1; SMN2 (0.68) SMN1; SMN2RAB9AALDH1A1NPC1L3MBTL1
SCHEMBL8395193 0.71 SMN1; SMN2 (0.68) SMN1; SMN2RAB9AALDH1A1NPC1L3MBTL1
SCHEMBL15945348 0.71 HTT (0.63) SMN1; SMN2RAB9AKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 SMN1; SMN2 4161/4885RAB9A 4377/4885KDM4E 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.